PLSE vs ROP · rev $835.0K vs P/E 41, rev $4.20B
Pulse Biosciences Inc (PLSE) versus Roper Technologies, Inc. (ROP) — a side-by-side from cached financials, not a winner call.
Pulse Biosciences Inc (PLSE) is a medical instruments & supplies company listed on US.
Roper Technologies, Inc. (ROP) is a software - application company listed on US.
Latest reported PLSE revenue for 2026-06-30 was $835.0K. Net income was -$43.2M. PLSE currently screens at market cap $1.03B.
Latest reported ROP revenue for 2026-06-30 was $4.20B. Net income was $1.68B. ROP currently screens at market cap $61.61B and trailing P/E 41.3.
PLSE currently screens at market cap $1.03B. ROP currently screens at market cap $61.61B and trailing P/E 41.3.
Not investment advice. Open the PLSE and ROP stock pages for the full models.
Not investment advice.